Clinical Trials Browser

Phase 1 × fluzoparib × Gastrointestinal × Clear all

NCT03026881 2017-03-07

A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients

Phase 1 Unknown

Gastrointestinal

Recurrence, Stomach Neoplasms